• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Protease-activated receptor 4 protects mice from Coxsackievirus B3 and H1N1 influenza A virus infection

tetano

Editor, Senior Moderator
Cell Immunol. 2019 Jul 3:103949. doi: 10.1016/j.cellimm.2019.103949. [Epub ahead of print]
[h=1]Protease-activated receptor 4 protects mice from Coxsackievirus B3 and H1N1 influenza A virus infection.[/h] Tatsumi K[SUP]1[/SUP], Schmedes CM[SUP]1[/SUP], Houston ER[SUP]1[/SUP], Butler E[SUP]1[/SUP], Mackman N[SUP]1[/SUP], Antoniak S[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] PAR4 is expressed by a variety of cells, including platelets, cardiac, lung and immune cells. We investigated the contribution of PAR4 to viral infections of the heart and lung. Toll-like receptor (TLR) 3-dependent immune responses were analyzed after co-stimulation of PAR4 in murine bone-marrow derived macrophages, embryonic fibroblasts and embryonic cardiomyocytes. In addition, we analyzed Coxsackievirus B3 (CVB3) or H1N1 influenza A virus (H1N1 IAV) infection of PAR4[SUP]-/-[/SUP] (ΔPAR4) and wild-type (WT) mice. Lastly, we investigated the effect of platelet inhibition on H1N1 IAV infection. In vitro experiments revealed that PAR4 stimulation enhances the expression of TLR3-dependent CXCL10 expression and decreases TLR3-dependent NFκB-mediated proinflammatory gene expression. Furthermore, CVB3-infected ΔPAR4 mice exhibited a decreased anti-viral response and increased viral genomes in the heart leading to more pronounced CVB3 myocarditis compared to WT mice. Similarly, H1N1 IAV-infected ΔPAR4 mice had increased immune cell numbers and inflammatory mediators in the lung, and increased mortality compared with infected WT controls. The study showed that PAR4 protects mice from viral infections of the heart and lung.
Copyright ? 2019 Elsevier Inc. All rights reserved.


[h=4]KEYWORDS:[/h] Influenza; Innate immune responses; Myocarditis; Protease-activated receptor 4

PMID: 31337508 DOI: 10.1016/j.cellimm.2019.103949
 
Back
Top Bottom